Department of Surgery, St. Antonius Hospital, PO Box 2500, Nieuwegein, 3430 EM, The Netherlands.
Department of Clinical Epidemiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Langenbecks Arch Surg. 2024 Nov 28;409(1):366. doi: 10.1007/s00423-024-03555-x.
The gold standard for treating acute cholecystitis is an early laparoscopic cholecystectomy. However, whether this still applies for a > 7-day existing cholecystitis remains heavily debated. Therefore, this systematic review investigates the safety of early laparoscopic cholecystectomy for a > 7-day existing cholecystitis.
PubMed and Embase were systematically searched for all studies comparing early laparoscopic cholecystectomy in patients with 0-7 versus > 7-day existing cholecystitis at time of surgery. Meta-analyses were performed on dichotomous and continuous outcomes with risk difference (RD) and mean difference (MD) as measures of effect.
A total of 3007 studies were screened, resulting in the inclusion of 13 non-randomised studies comprising 5481 patients. Of these, 4690 received cholecystectomy within 7 days, and 791 after 7 days. Operating times (MD -11.8 min; 95% CI [-18.4; -5.2]) and total hospital stay (MD -2.7 days; 95% CI [-4.0; -1.4]) were longer in the > 7-day group. However, no significant risk difference was found for combined major complications: bile duct injury/leakage and bowel injury (RD -1.0%; 95% CI [-2.3; 0.3]), for complications graded Clavien-Dindo ≥ 3 (RD -0.3%; 95% CI [-2.5; 1.9]), or for conversions (RD -1.5%; 95% CI [-3.9; 0.9]).
Early laparoscopic cholecystectomy for cholecystitis after the 7-day barrier might be harder, as reflected by longer operating times. However, a significant increase in complications or conversions was not found. Due to the risk of bias and lack of well-powered studies directly comparing early cholecystectomy after 7 days with alternative strategies, strong recommendations cannot be made. Meanwhile, it is advised to carefully weigh the treatment options in case of a > 7-day existing cholecystitis, based on patient's characteristics and surgeon's experience.
治疗急性胆囊炎的金标准是早期腹腔镜胆囊切除术。然而,对于已经存在超过 7 天的胆囊炎,这种方法是否仍然适用,仍存在很大争议。因此,本系统综述调查了早期腹腔镜胆囊切除术治疗已经存在超过 7 天的胆囊炎的安全性。
系统检索了 PubMed 和 Embase 中的所有研究,比较了手术时存在 0-7 天和超过 7 天的急性胆囊炎患者的早期腹腔镜胆囊切除术。对二分类和连续结局进行了荟萃分析,采用风险差异(RD)和均数差(MD)作为效应量。
共筛选出 3007 篇研究,纳入了 13 项非随机研究,共纳入 5481 例患者。其中,4690 例在 7 天内接受了胆囊切除术,791 例在 7 天后接受了胆囊切除术。手术时间(MD-11.8 分钟;95%CI[-18.4;-5.2])和总住院时间(MD-2.7 天;95%CI[-4.0;-1.4])在超过 7 天组更长。然而,联合主要并发症(胆管损伤/漏和肠损伤)、Clavien-Dindo 分级≥3 的并发症(RD-0.3%;95%CI[-2.5;1.9])或中转手术(RD-1.5%;95%CI[-3.9;0.9])的风险差异无统计学意义。
对于超过 7 天胆囊炎的患者,早期腹腔镜胆囊切除术可能更具挑战性,反映在手术时间更长。然而,并未发现并发症或中转手术明显增加。由于存在偏倚风险,且缺乏直接比较 7 天后早期胆囊切除术与替代策略的高质量研究,因此无法做出强有力的推荐。同时,建议根据患者的特征和外科医生的经验,仔细权衡超过 7 天的胆囊炎的治疗选择。